Search the Newsreel

Albany International (NYSE:AIN) Posts Earnings Results, Beats Expectations By $0.08 EPS

Albany International (NYSE:AIN) reported strong Q2 earnings, with an EPS of $0.82, surpassing analyst expectations by $0.08, and a 5.8% increase in revenue year-over-year. Despite a cautious "Reduce" rating from analysts and a target price below its current trading, the company updated its Q3 …

Irish remove Elbit fog landing system from gov’t jet

Ireland has decided to remove an Israeli-made fog landing system, Elbit's FalconEye, from its new €53 million government jet due to its pro-Palestinian stance and boycott of Israeli products. This decision may compromise the aircraft's ability to land in foggy and hazardous weather conditions, …

Albany International (AIN) Q2 Earnings Surpass Estimates

BBVA Closes EUR1.5 Billion Share Buyback Tranche

BBVA has successfully completed a share buyback program totaling EUR1.5 billion. This action is part of the bank's strategy to return capital to shareholders. The buyback involved the acquisition of a significant number of shares, which are expected to be cancelled.

ALBANY INTL ($AIN) Releases Q2 2026 Earnings | AIN Stock News

ALBANY INTL ($AIN) Releases Q2 2026 Earnings

Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), LB Pharmaceuticals, Inc. (LBRX) and SpaceX (SPCX)

Analysts have provided insights on Evommune, Inc. (EVMN), LB Pharmaceuticals, Inc. (LBRX), and SpaceX (SPCX). H.C. Wainwright reiterated a Hold rating for Evommune, while Piper Sandler maintained a Buy rating for LB Pharmaceuticals with a $78.00 price target. RBC Capital also kept a Buy …

Albany International Reports Second-Quarter 2026 Results

Albany International (NYSE:AIN) reported a strong second quarter in 2026, with net revenue increasing by 6% to $329.5 million and diluted EPS jumping 97% to $0.61. The company achieved its strongest Adjusted EBITDA in two years, reaching $57.8 million, an 11% increase year-over-year, driven …

Aalberts reports the progress of its share buyback programme 27 July – 31 July 2026

Aalberts N.V. Utrecht, 4 August 2026 Aalberts today reports that it has repurchased 64,000 of its own shares in the period from 27 July 2026, up and including 31 July 2026 for an amount of EUR 2,699,751.18 so at an average share price of …

Heidelberger Druckmaschinen Aktie: Verlustjahr 2026/2027 bestätigt

Albany International (AIN) Earnings Date and Reports 2026 $AIN

Here's How to Play Albemarle Stock Before Q2 Earnings Release

Albany International (NYSE:AIN) Issues Q3 2026 Earnings Guidance

Albany earnings beat by $0.11, revenue fell short of estimates

DigitalBridge Group (NYSE:DBRG) Issues Earnings Results, Beats Expectations By $0.05 EPS

Jefferies eleva el precio objetivo de BBVA y su previsión de beneficios hasta 2028

Weekly Recap: Q2 revenue dip, EPS cut and Atmos and Vision adoption rise

Dolby Laboratories (DLB) reported Q2 revenue of $305 million and adjusted EPS of $0.69, with net income at $28.6 million. Despite a mid-year FY26 EPS cut to $4.33 and an 11.3% operating margin, Dolby Atmos and Vision continue to expand across various platforms, supported …

L.B. Foster Company to Report Second Quarter 2026 Results on August 10, 2026

L.B. Foster Company announced it will release its second quarter 2026 financial results on Monday, August 10, 2026, after the market closes. The company will also host a conference call and webcast on Tuesday, August 11, 2026, at 10:00 a.m. ET to discuss the …

Elbit Systems Unveils New Maritime Concept to Convert Commercial Cargo Ships into Dedicated UAV Launching Platforms

Elbit Systems has revealed a new maritime concept to transform commercial cargo ships into platforms dedicated to launching UAVs, specifically the Hermes 650 Spark fixed-wing drone. Each converted vessel would carry 9-12 drones, along with necessary deck infrastructure and control systems, operating as a …

LB Pharmaceuticals (LBRX) holder acquires 286K pre-funded warrants

Deep Track Biotechnology Master Fund, Ltd., a ten percent holder of LB Pharmaceuticals (LBRX), purchased 286,205 pre-funded warrants to buy LBRX common stock at $34.9399 per warrant on July 30, 2026. This transaction increased its direct pre-funded warrant position to 664,649. These warrants are …

Form 4 LB Pharmaceuticals Inc For: 3 August By Investing.com

This article reports on a Form 4 filing for LB Pharmaceuticals Inc. for August 3rd. Form 4 filings are regulatory documents submitted to the SEC by company insiders, indicating changes in their ownership of company stock. The article itself is brief, essentially serving as …

Albertsons CEO Susan Morris Buys $450,000 on the Open Market. What Does This Mean for ACI Investors?

Key Points The transaction involved 39,409 shares acquired for ~$450,000 on July 28, 2026. The acquisition increased the insider's direct equity position by 4%. Morris now directly holds ~1.1 million shares of Class A common stock, with no indirect holdings reported in this filing. …

Albertsons Companies, Inc. (ACI) CFO buys 9,000 shares at $11.48

Albertsons Companies, Inc.'s President & CFO, Sharon McCollam, purchased 9,000 shares of Class A common stock at $11.48 per share on July 31, 2026. This open-market transaction increased her direct holdings to 567,051 Class A common shares. The filing indicates a positive sentiment towards …

Piper Sandler reiterates Overweight on LB Pharmaceuticals stock

Piper Sandler has reiterated an Overweight rating and a $78.00 price target for LB Pharmaceuticals (NASDAQ:LBRX), citing the company's strong financial position and promising drug pipeline. The stock has surged significantly over the past year, and the firm highlights upcoming clinical trial data for …

PLBY Group (PLBY) Projected to Announce Earnings on Monday

PLBY Group (NASDAQ:PLBY) is projected to announce its Q2 2026 earnings on Monday, August 10th, with analysts forecasting a loss of $0.0033 per share and revenue around $29.7 million. The company's stock is under pressure, trading near its 52-week low, and faces challenges including …

Price to earnings forward of LB Pharmaceuticals Inc – NASDAQ:LBRX

This article provides financial information for LB Pharmaceuticals Inc (NASDAQ:LBRX), specifically focusing on its forward price-to-earnings ratio. It indicates that the market is currently closed with no trades. The content is primarily a data placeholder on TradingView, detailing various products, community features, and company …

LB Pharmaceuticals (NASDAQ:LBRX) Hits New 12-Month High - Still a Buy?

LB Pharmaceuticals (NASDAQ:LBRX) recently hit a new 52-week high of $41.71, trading up 7.7% and giving the company a market capitalization of $1.24 billion. Analyst sentiment is largely positive, with a "Moderate Buy" consensus and price targets ranging from $45 to $46. The clinical-stage …

L.B. Foster to report Q2 2026 results on August 10 with a live webcast conference call.

L.B. Foster Company announced it will release its second quarter 2026 financial results on August 10, 2026, before the market opens. The company will host a live webcast conference call at 8:30 A.M. Eastern Time to discuss its operating results, market outlook, and business …

Enterprise value to revenue forward of Albright Metals Ltd Warrant 2026-06.01.29 on Albright Mtl – ASX:ABRO

Snag This Bargain 5.9% Yield Dividend Stock Even Cheaper Than Chief Executive Officer Morris Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on July 28, Albertsons Companies Inc's Chief Executive Officer, Susan Morris, invested $449,937.80 into 39,409 shares of ACI, …

Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?

Dolby Laboratories, Inc. DLB expects a sharp fiscal fourth-quarter rebound after third-quarter revenues fell 3.3% year over year to $305 million. The guidance midpoint points to approximately 23% growth, creating a clear test of whether newer licensing opportunities can offset uneven foundational businesses. The …

LYB Q2 Earnings Call Points to a Prolonged Supply Reset

LyondellBasell Industries N.V. LYB used its second-quarter 2026 earnings call to emphasize that Middle East supply disruptions have reshaped petrochemical trade flows and could support margins beyond the near term. Management also framed the quarter as evidence that portfolio pruning, cost reductions and advantaged …

Gear Up for Albemarle (ALB) Q2 Earnings: Wall Street Estimates for Key Metrics

Wall Street analysts expect Albemarle (ALB) to post quarterly earnings of $3.35 per share in its upcoming report, which indicates a year-over-year increase of 2945.5%. Revenues are expected to be $1.59 billion, up 19.2% from the year-ago quarter. The consensus EPS estimate for the …

Company News for Aug 3, 2026

Chevron Corp.'s (CVX) shares rose 2.4% after reporting second-quarter 2026 adjusted earnings of $6.06 per share, surpassing the Zacks Consensus Estimate of $5.80 per share. Shares of ExxonMobil Holdings Corp. (XOM) fell 1% after posting second-quarter 2026 adjusted earnings of $3.52 per share, missing …

PLBY Q2'26 Earnings: revenue estimate is 29.69M USD

Leaked Elbit documents reportedly show it was in talks to sell UAE advanced drones

Leaked internal documents from Elbit Systems, Israel’s largest arms manufacturer, suggest the company was in advanced talks to sell dozens of strategic drones and other advanced armaments to the United Arab Emirates. The documents, published by an Iran-backed hacker group, include price proposals and …